Deadly Medicines and Organised Crime :How Big Pharma Has Corrupted Healthcare

Deadly Medicines and Organised Crime

Deadly Medicines and Organised Crime :How Big Pharma Has Corrupted Healthcare

hardback
Published: 11 July, 2017
Standard worldwide delivery by Tue, July 28 - Thu, August 6
Order within 0
Condition: NEW
$193.19
RRP $214.49
You save $21.30 (10%)
Price includes shipping
Available 5 in stock
- +
FREE Returns within 30 days

Description

This book is devoted to building up the case that the drug industry has systematically corrupted science to play up the benefits and play down the harms of their drugs. It describes the activities of the drug industry to organised crime.
See more

More Details

Type Book
ISBN13 9781138443471
ISBN10 1138443476
Number Of Pages 324
Item Weight 760 g
Publisher / Reseller Taylor & Francis Ltd
Format hardback
See More +

Author's Bio

Professor Peter C Gøtzsche graduated as a Master of Science in biology and chemistry in 1974 and as a physician in 1984. He is a specialist in internal medicine; he worked with clinical trials and regulatory affairs in the drug industry 1975–83, and at hospitals in Copenhagen 1984–95. He co-founded The Cochrane Collaboration in 1993 and established The Nordic Cochrane Centre the same year. He became professor of Clinical Research Design and Analysis in 2010 at the University of Copenhagen., Peter Gøtzsche has published more than 50 papers in ‘the big five’ (BMJ, Lancet, JAMA, Annals of Internal Medicine and New England Journal of Medicine) and his scientific works have been cited over 10000 times., Peter Gøtzsche has an interest in statistics and research methodology. He is a member of several groups publishing guidelines for good reporting of research and has co-authored CONSORT for randomised trials (www.consort-statement.org), STROBE for observational studies (www.strobe-statement.org), PRISMA for systematic reviews and meta-analyses (www.prisma-statement.org), and SPIRIT for trial protocols (www.spirit-statement.org). Peter Gøtzsche is an editor in the Cochrane Methodology Review Group.

Show more